0000000000392580

AUTHOR

S Adami

showing 3 related works from this author

The evolution of European Medicines Agency drug approval: the adaptive licensing

2016

Editorial without abstract

Settore BIO/14 - FarmacologiaDrug approval Adaptive licensing
researchProduct

Incidence and costs of hip fractures compared to acute myocardial infarction in the Italian population: a 4-year survey

2007

Introduction Few data are available about the incidence and costs of hip fractures in Italy. We aimed to determine the impact of hip fractures vs. acute myocardial infarction (AMI). Methods We studied the national hospitalization database to calculate their incidence and costs in adults aged ≥45 between 1999 and 2002. Results In 2002, there were 86,719 hip fractures with a 10.0% increase over 4 years. We observed a predominance of women (77.1%) and a strong age effect: 92.7% of patients were ≥65 years old and 80% of fractures occurred in women aged ≥75, showing a clear relationship with the incidence of osteoporosis. Hospitalizations due to AMI after 45 years of age in 1999 were only 9% hig…

Malemusculoskeletal diseasesAgingmedicine.medical_specialtyHeart diseaseCostEpidemiologyEndocrinology Diabetes and MetabolismOsteoporosisacute myocardial infarctionPoison controlhip fractures; myocardial infarctionAMIAge Distributionhip fracture myocardial infarction italian populationInjury preventionEpidemiologyHumansMedicinecardiovascular diseasesMyocardial infarctionSex Distributionhealth care economics and organizationsAgedbusiness.industryIncidenceIncidence (epidemiology)Health Care CostsLength of StayMiddle Agedmedicine.diseaseHospitalizationmyocardial infarctionItalyhip fractureHealth Care Surveyship fracturesEmergency medicineOrthopedic surgeryPhysical therapyFemaleitalian populationbusiness
researchProduct

Determinants of adherence to osteoporosis treatment in clinical practice.

2006

Introduction: Poor adherence to prescribed treatments is widespread in clinical practice and this can lead to potentially life-threatening events. This problem is apparently very common for osteoporosis treatment but the causes of discontinuation and low compliance are complex and poorly defined. Methods: Global adherence to osteoporosis treatment was specifically addressed in a nation-wide survey carried out in 9851 postmenopausal women referred to 141 Italian centres for osteoporosis management for a follow-up assessment, at least one year after having been prescribed a treatment with one of the following drugs: calcium±vitamin D supplements alone (CaVitD), hormone replacement therapy (HR…

medicine.medical_specialtySettore MED/09 - Medicina InternaHormone Replacement TherapyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentOsteoporosisosteoporosis; Determinants; Treatment adherence; Treatmentadherence; compliance; osteoporosis; persistence; treatmentInternal medicinemedicineTreatment adherenceHumansRaloxifeneDosingVitamin DDeterminantsOsteoporosis PostmenopausalAgedAdherence Compliance Osteoporosis Persistence TreatmentBone Density Conservation Agentsbusiness.industryHormone replacement therapy (menopause)Middle Agedmedicine.diseaseosteoporosisRheumatologyDiscontinuationMenopauseTreatmentItalyOrthopedic surgeryPhysical therapyPatient ComplianceCalciumFemalebusinessmedicine.drugOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
researchProduct